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I. Introduction 
 
La cavité crânienne est une structure inextensible qui contient l’encéphale, le 
système vasculaire ainsi que le liquide céphalo-rachidien (LCR). Les valeurs de 
pression intracrânienne évoluent constamment, considérant toutefois comme 
normale une valeur ne dépassant pas 15 mm Hg. L’hypertension intracrânienne 
(HTIC) résulte d’une augmentation des volumes à l’intérieur de la cavité 
crânienne et peut résulter de plusieurs phénomènes: le développement d’un 
processus expansif, une accumulation de LCR à l’intérieur des cavités 
ventriculaires (hydrocéphalie), une stase par obstacle au retour veineux ou en 
cas de vasodilatation physiologique ou pathologique, ainsi qu’un œdème 
cérébral consécutif à un processus pathologique, qu’il soit cérébral ou extra 
cérébral. 
Le but de ce travail de thèse est de parcourir de manière systématique la 
littérature et de répertorier les études disponibles analysant l’association directe 
entre le pronostic des patients ayant subi un traumatisme cranio-cérébral (TCC) 
et les valeurs ainsi que les évolutions (« pattern ») de pression intracrânienne 
(PIC). Le but final est d’évaluer si la pression intracrânienne est un facteur 
indépendant influençant le pronostic neurologique et vital des patients ainsi que 
d’identifier des seuils de valeur de pression intracrânienne au delà desquels le 
pronostic neurologique et/ou vital s’assombrit.  
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II. Méthode      
 
La recherche bibliographique a été réalisée en utilisant le moteur de recherche 
« Medline » ainsi que la base de données « Cochrane », incluant des articles 
publiés entre 1966 et 2006. Les recherches ont été effectuées sans restriction de 
langue et les termes suivants ont été utilisés : “intracranial pressure", "severe 
head injury", "cerebral perfusion pressure ", "traumatic brain injury ", "intracranial 
hypertension", "outcome", "head trauma", "intensive care". Les combinaisons 
suivantes ont été utilisées: "intracranial pressure AND outcome", " severe head 
injury AND outcome", "intracranial pressure AND cerebral perfusion pressure", 
"cerebral perfusion pressure AND outcome".  
 
III. Analyse Statistique 
 
Le but premier de cette étude est d’estimer s’il existe une association entre les 
valeurs de PIC et le pronostic neurologique (évalué au moyen de l’échelle 
« Glasgow Outcome Scale » (GOS)) à moyen terme (3 à 12 mois après la sortie 
de l’hôpital) en utilisant un modèle d’odds. Nous avons également étudié la 
relation entre les profils de PIC et le GOS. Nous avons utilisé des modèles 
logistiques pour étudier l’influence de valeurs croissantes de pression 
intracrânienne sur le pronostic neurologique. Toutes les analyses ont été 
effectuées avec le programme de statistiques STATA version 8.2 (Stata Corp, 
College Station, TX). 
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 IV. Résultats  
 
Parmi les 555 articles évalués, 15 articles évaluant les valeurs et/ou évolutions 
de la pression intracrânienne en fonction du GOS ont été étudiés. Sept études 
ont décrit précisément l’association entre le pronostic et/ou les valeurs/pattern de 
pression intracrânienne. Nous avons identifié plusieurs paramètres reportés dans 
les différentes études : âge, présence d’une masse nécessitant une évacuation 
chirurgicale, le score de Glasgow initial, le traitement initial, la nature et la durée 
du monitorage de la PIC, l’élévation de la tête, l’utilisation d’une hyperventilation, 
de stéroïdes, d’agents osmotiques, d’un drainage du LCR, de barbituriques ainsi 
que la surveillance du status volémique et la survenue d’une hypoxémie et/ou 
hypotension systémique. Nous présentons ci-dessous les résultats. 
 
• Valeurs de pression intracrânienne et devenir neurologique :  
Nous avons évalué, à partir de 4 études, l’association entre les valeurs de PIC et 
le devenir de 409 patients. Le modèle statistique indique que le risque de 
développer un pronostic neurologique défavorable (défini comme une invalidité 
sévère, un état végétatif ou la mort) augmentait avec les valeurs de PIC. L’odds 
ratio (OR) comparant les valeurs de pression comprises entre 20 et 40 mm Hg 
avec celles inférieures à 20 mm Hg est de 2.3 (95% CI: 1.37, 3.89). L’OR 
comparant les valeurs supérieures à 40 mm HG et inférieures à 20 mm Hg est de 
4.1 (95% CI: 2.65, 6.29). L’OR comparant un pronostic favorable (défini comme 
une récupération complète) avec tous les autres évolutions pour des patients 
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présentant une PIC supérieure à 40 mm Hg par rapport à ceux présentant une 
PIC normale était diminué (OR: .19 [95% CI: .11, .33]). Par contre, la 
comparaison entre des pronostics défavorables et favorables concernant des 
valeurs de PIC comprises entre 20 et 40 mmHg et de valeurs supérieures à 40 
mm HG (avec comme valeur de référence une PIC inférieure à 20 mm Hg) n’était 
pas significativement augmentée (1.6 [95% CI: .83, 3.10] et 1.6 [95% CI: .91, 
2.81] respectivement). Finalement on observe une augmentation de l’OR 
comparant la survenue d’un décès avec toutes les autres évolutions pour chaque 
augmentation des valeurs de PIC: 2.9 [95% CI: 1.45, 5.60] pour une PIC entre 20 
et 40, 5.7 [95% CI: 3.35, 9.59] pour une PIC supérieure à 40, une PIC inférieure 
à 20 étant la référence. 
 
• 2. Profil de pression intracrânienne et devenir neurologique : 
Les profils de PIC ont été divisé en trois catégories: normale, élevée mais 
réductible et réfractaire au traitement spécifique. L’association entre les profils de 
pression intracrânienne et le devenir a pu être analysée dans une cohorte de 677 
patients (issus de 5 études). Des valeurs normales sont associées à un pronostic 
favorable (récupération complète ou récupération modérée) dans 77% des cas. 
Des profils de pression intracrânienne réfractaire sont associés à une 
augmentation considérable de la mortalité (96%). L’OR concernant le pronostic 
favorable est considérablement réduit chez les patients présentant une 
hypertension intracrânienne réfractaire (OR: .01, 95%CI: .003, 0.32). L’OR 
concernant la survenue du décès des patients était augmenté chez les patients 
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ayant présenté une PIC élevée et secondairement diminuée par un traitement 
spécifique en comparaison avec une PIC constamment physiologique (OR: 2.1, 
95% CI: 1.41, 3.15). De même, l’OR entre un pronostic favorable et une invalidité 
sévère/état végétatif est cinq fois plus élevé chez des patients présentant une 
élévation de la pression intracrânienne avec une réduction secondaire.  
 
V. Discussion 
 
La principale découverte de cette analyse systématique est qu’en dépit de la 
multitude d’articles publiés et analysants la relation entre la pression 
intracrânienne et le devenir des patients ayants subi un traumatisme cranio-
cérébral, nous ne disposons d’aucune étude prospective randomisée évaluant la 
mortalité/morbidité en fonction des valeurs de pressions intracrâniennes. Une 
des explications réside dans le fait que le monitorage de la pression 
intracrânienne fait partie intégrante des protocoles de neuro-traumatologie. Il est 
donc délicat d’établir une étude comprenant un groupe de patients traités selon 
un protocole, indépendamment des valeurs de pression intracrânienne. De plus, 
une telle étude nécessiterait une cohorte de patients conséquente pour aboutir à 
des résultats significatifs. 
A partir des données existantes, nous ne pouvons pas affirmer que la pression 
intracrânienne est un facteur indépendant de pronostic chez les patients 
souffrant d’un traumatisme cranio-cérébral. De même, la littérature publiée ne 
permet pas de considérer le monitorage de la pression intracrânienne comme 
améliorant le pronostic, même si l’expérience clinique tend à suggérer son utilité. 
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Finalement, un intérêt croissant pour le concept de la pression de perfusion 
cérébrale ces dix dernières années dans les protocoles de neuro-traumatologie a 
fait son apparition, soulignant la complexité de la prise en charge. 
 
 
VI. Conclusion 
 
Il ressort de ce travail que l’évolution de la pression intracrânienne, sa réponse 
au traitement plus que la valeur elle-même pourrait être un élément prédicateur 
du devenir neurologique fonctionnel des patients. Cependant, pour démontrer 
ces hypothèses, des études prospectives incluant une cohorte importante 
seraient nécessaires. 
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1. INTRODUCTION 
 
Intracranial pressure (ICP) value fluctuates over time. These fluctuations are 
physiological and even when a transient elevation of ICP is measured, it never 
jeopardizes cellular metabolism. However, after traumatic brain injury (TBI), ICP 
elevation as well as fluctuations may represent worsening conditions for the brain cells. 
Thus, monitoring the ICP has been regarded since many years as an important tool 
when caring these patients. Development in cerebral monitoring technology has allowed 
to use it closely and continuously to monitor ICP. It is accepted that the risk / benefit 
ratio is in favor of the latter, particularly when considering the modern technology.  
Presently however, limited information concerning the consequences of raised 
intracranial pressure after head trauma on the functional and structural integrity of the 
brain has been reported. Indeed, few studies have been published in the literature which 
prospectively report on the outcome of the severe head injuries patients, looking in detail 
for variation of ICP. Furthermore, no concrete model has been established to predict the 
appearance and behavior of multiple intracranial pressure variations on the outcome 
(determined by the Glasgow outcome coma scale (GOS)). Moreover, some authors 
even consider that the intracranial pressure data alone is no value to predict outcome. 
This lack of evidence-based medicine explains why no guidelines can be recommended 
to provide universal treatment of raised intracranial pressure secondary to varied 
pathological situations. In response to the absence of scientific proof of the utility to 
monitor ICP, the development of the concept of multimodal monitoring associating ICP, 
cerebral perfusion pressure (CPP) and indirect metabolism has been proposed.  
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Firstly, this thesis will develop a thorough review of the cerebral physiology. Most of the 
informations presented below are based on textbooks of critical care medicine 1-3. 
Secondly, in order to explore some aspects of the consequences of episode of raised 
intracranial pressure after severe brain traumatic injuries, we will identify the degree of 
evidence provided by the existing literature on the effect on outcome of variable ICP 
value. This work will try to determine if a recorded ICP value higher than 40 mmHg is an 
independent risk factor for worse outcome. Furthermore, this study will also look for 
lower ICP values stratifying patients by steps of 10 mmHg. The meta-analysis 
methodology will be used to try to answer this question.  
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2. ANATOMIC REVIEW 
 
The brain and its envelopes: 
The skull is a rigid bony structure containing the brain, Cerebro-Spinal Fluid (CSF), and 
arterial and venous blood.  
The brain, a non-compressible element, is enclosed by different layers of tissue which 
compose the meninges. The dura matter (outermost), the arachnoid and the pia matter 
(innermost). The dura matter, a rigid and fibrous membrane, is made of two layers 
consisting in the external periosteal layer and the internal dura. The latter extends into 
the whole intracranial cavity, forming two folds: the tentorium and the falx (see figure 1). 
These extensions delimitate three compartments: two supratentorials containing the 
right and left cerebral hemispheres and one infratentorial. The space between the dura 
and the arachnoid is the subdural space. Another space lies between the pia matter and 
arachnoid and is called the subarachnoid space: in this space circulates CSF, whose 
functions are multiple and will be discussed later.  
A virtual space, denominated epidural space, lies between the external layer of the dura 
and the calvarium. Because the external layer of the dura is tightly related to the bone, 
this space does not exist in normal healthy people: however there are multiple 
conditions in which this space widens as in the case of epidural hematoma or epidural 
abscesses.  
The second layer is the arachnoid which is closely associated with the pia matter. It 
consists in a fragile, fine and elastic membrane connected by trabeculae to the pia. The 
arachnoid is profusely vascularized. The arachnoid villi (Paccioni’s granulations) are 
invaginations of this layer into the dural venous sinuses. Paccioni’s granulations function 
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is to reabsorb the CSF, circulating into the subarachnoid space, and to transfer it to the 
venous circulation. This reabsorption system allows CSF to be drained by a 
unidirectional valve. The subarachnoid space present seven larger spaces called 
cisternae: cerebellomedullary, interpeduncular, pontine, ambiens, lateral fossa, 
chiasmatic, and superior. The pia is intimately attached to the brain. The pia and 
arachnoid are very closely related and often considered as one entity called 
leptomeninges.  
The schema below (figure 1) presents the intracranial cavity (based on the “Atlas of 
human anatomy”, Frank Netter). 
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 The ventricular system: 
Deep into the brain are cavities which are called ventricles. The ventricular system of the 
central nervous system (CNS) is composed of two lateral ventricles (each composed of 
an anterior horn located in the frontal lobe, a body and antrium in the parietal lobe, a 
posterior horn in the occipital lobe and a inferior horn in the temporal lobe), the third and 
fourth ventricle (located dorsally to the pons and medulla). The lateral ventricles are 
joined together and lead to the third ventricle then via a small conduit, the foramen 
Monroe. Then this latter is able to access to the fourth ventricle through the aqueduct of 
Sylvius.  
At this point, the CSF flowing through the ventricles gain access to the subarachnoid 
space via the two foramina of Luschka and the foramen of Magendie.  
 
The cerebrospinal fluid: 
As previously described, the CSF circulates in the ventricular system and the 
subarachnoid space. Choroids plexuses regulate the production of CSF, the resorption 
being ensured by the arachnoid villi. Most of the CSF is secreted actively (with virtually 
no regulation) by the choroids plexuses located in the lateral ventricles and to a lesser 
degree by the third and fourth ventricles. Thus, under normal condition, a balance 
between these two variables exists. The total volume of CSF is 125 ml and the rate of 
CSF production is approximately constant (500 mL/day). The CSF has different 
functions: firstly a protective one allowing the brain to float in the intracranial cavity, and 
providing a protection against static and dynamic shocks. Secondly, through the 
perivascular spaces located in the pia matter, it creates an adequate environment for the 
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activity of the brain by excreting metabolites and regulating the chemical surrounding of 
the CNS. 
 
The vasculature of the brain: 
Two arterial trunks bring oxygenated blood to the brain: the anterior system consisting in 
the internal carotid arteries and the posterior system with the vertebrobasilar axis. The 
internal carotid artery arises from the common carotid artery and further divides into two 
terminal branches, the anterior cerebral artery and the middle cerebral artery (some 
collaterals such as the ophtalmic and hypophyseal arteries emergent before the division 
into the terminal branches). The vertebral component of the posterior system gives rise 
to the PICA (posterior inferior cerebellar artery) and the anterior spinal artery. The 
basilar artery results of the junction of the two vertebral arteries at the inferior border of 
the pons which divides more distally into two posterior cerebral arteries at the superior 
part of the pons (collaterals rise from the basilar artery: the anterior inferior cerebellar, 
internal auditory, pontine and superior cerebellar arteries). At the basis of the brain, both 
the anterior and posterior systems form an arterial circle which function is to provide 
suppleancy in case of localized vascular defect (see figure 2). The anterior 
communicating artery allows the two anterior cerebral arteries to communicate in front of 
the optic chiasma and the two posterior communicating arteries connect the internal 
carotid artery with the posterior cerebral artery on each side. This system called the 
Willis circle presents many anatomical variations. Other communicating systems such as 
between the extracranial and intracranial vessels allows other collateral circulation.  
Venous circulation of the cerebral hemispheres is provided by a system of deep and 
superficial veins. The former drain the inner parts of the white matter, including basal 
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ganglia and some parts of the diencephalon. Most of this system finally join the great 
vein of Gallen. The latter include the veins arising from the cerebral cortex and the 
underlying white matter. These two systems are enveloped in the dural sinuses, which 
are considered as low-pressure channels for venous flow back to the systemic 
circulation, located between the two layers of the dura: 
-the superior and inferior sagittal sinuses 
-the straight sinus 
-the sigmoid sinus 
-the transverse sinus 
-the cavernous sinus 
-the superior and inferior petrosal sinuses 
The figure (figure 2) presented below describes the arterial vasculature of the brain 
(based on “Atlas of human anatomy”, Frank Netter). 
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3. PHYSIOPATHOLOGY OF THE INTRACRANIAL PRESSURE AND 
CEREBRAL PERFUSION PRESSURE 
 
The intracranial pressure: 
The skull is an enclosed and rigid envelop containing the three determinants of the 
intracranial pressure (ICP) namely the brain parenchyma (80%), cerebral blood volume 
(CBV; 10%) and cerebrospinal fluid (CSF; 10%). Each of these three elements can be 
submitted to important volume variations independently or simultaneously. 
• Increase in cerebral mass via growing process, hemorrhage or edema 
• Increase in CBV following venous circulation’s obstruction 
• Increase in CSF via increased production, decreased resorption or impaired flow.  
A constant intracranial pressure (a normal range of ICP is between 0 and 15 mmHg), 
ultimately to allow a constant cerebral oxygen delivery, is maintained under normal 
condition by adjusting the balance between respective volume of these three elements 
(The Monro-Kellie doctrine). Because the brain is essentially non-compressible, CSF 
and CBV are the main elements implicated by this compensatory mechanism. Firstly, a 
displacement of the cerebrospinal fluid in the spinal canal in response to an increase in 
intracranial volume is observed. A schematic description of this compensatory 
phenomenon is illustrated on the Pressure/Volume curve (Point B, figure 3). Then a 
cerebral venoconstriction occurs, which will decrease CBV by blood volume 
displacement into the internal jugular venous system. However, if the expanding process 
continues to grow, the buffer capacity is overwhelmed and intracranial pressure will rise 
in an exponential fashion. When the volume expansion of an element is progressive (i.e. 
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as occurs with the development of a tumoral mass), two other compensatory 
mechanisms are developed: a diminution in the production of CSF and brain's atrophy.  
The figure 3 presents the pressure/volume relationship (Monro-kellie doctrine) in the 
intracranial cavity.  
CPP 
          Volume 
A B
C
Δ Volume 
Δ Pressure
Pressure
 
Where CPP is the cerebral perfusion pressure. 
 
The cerebral perfusion pressure (CPP): 
The flow (Q) in a blood vessel depends on two factors: 
Firstly a pressure gradient between the two extremities of the vessel, which represents 
the driving force of the flow. The cerebral blood flow makes no exception: the mean 
arterial pressure (MAP) represents the inflow and the central venous pressure jugular 
venous pressure, the outflow pressure. 
Secondly the resistance to flow, i.e. the vascular resistance. The definition of resistance 
includes the dimensions of the tube in which the fluid flows, the rheological properties of 
this fluid, and two constants. The hydraulic resistance of any individual vessel is 
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principally determined by its caliber, which varies inversely as the fourth power of the 
radius. The contraction or relaxation of the circular smooth muscle cells induces such 
changes in caliber, and is thus constantly implicated in physiologic regulation 
mechanisms to ensure sufficient and constant nutrients delivery. Moreover the 
transmural pressure (defined as the internal to external pressure difference) is an 
important determinant of the resistance affecting the vessel diameter: thus, the lowest 
resistance is associated with the greatest transmural pressure across the wall of the 
vessel. 
 
The following equation summarizes the two concepts listed above: 
R= (Pi-Po)/Q= 8ηl/πr 
Where R is the resistance, Pi is the internal pressure, Po the external pressure, Q is the flow, η is the 
viscosity, r is the radius, π is the number pi and l is the length of the vessel. 
The cerebral perfusion pressure is defined as the difference between MAP and CVP in 
normal healthy people. In these physiological conditions, the ICP is not a determinant of 
the CPP and thus of the cerebral blood flow (CBF). Pathological situations associated 
with raised ICP tend to alter this relation as ICP becomes the limiting downstream 
pressure. Thus, CPP equation is modified accordingly: 
CPP = MAP - ICP = MAP - CVP 
In this condition, ICP acts indirectly on the vascular resistance. By decreasing the 
transmural pressure across the wall of the cerebral vessels, raised ICP decreases its 
caliber with a subsequent increase in the resistance. 
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The CPP is tightly regulated by multiple mechanisms (neural, humoral, myogenic), the 
pressure autoregulation being the most noticeable. This regulatory phenomenon is set 
up to provide constant nutrients delivery: All these elements will be discussed later. 
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4. CEREBRAL METABOLISM 
 
The brain receives 15 to 20% of the cardiac output. The global CBF varies between 50 
and 55 mL/100g brain tissue/minutes, with a physiological range between 20 and 80 ml, 
depending on the state of activation and the metabolic rate of the individual regions. It is 
important to mention that CBF is a non homogenous process adapted to the cerebral 
activity and thus global CBF represents in fact the integration of multiple cerebral local’s 
flow. In comparison to other organs the brain which weights 1500g (2% of the total body 
weight), presents a high and continuous metabolic rate. It extracts more oxygen than 
other organs of the body and as a consequence the saturation of venous blood from the 
brain is relatively low. Furthermore, the brain has no capacity to store large reserve of its 
exclusive metabolic substrates, i.e. glucose and oxygen. In a healthy person, 
approximately 30-40% of oxygen and 10% of the glucose delivered to the brain are 
consumed. Moreover, even if under certain circumstances such as during starvation, the 
brain metabolism may use alternate substrates such as ketones bodies or fatty acids, it 
can be done only under strict aerobic condition. 
In clinical practice, global approach of cerebral metabolism can be measured using 
cerebral oxygen consumption (CMRO2) which can be calculated with the following 
equation: 
CMRO2=(C(a-v)O2) × CBF 
Where C(a-v)O2 represents the arterial-jugular venous oxygen content difference. 
In healthy people, CBF and metabolism are closely coupled thus, CMRO2 matches the 
global CBF and C(a-v)O2 remains constant. An average value is considered to be of 3,5 
mL/100g/minutes. A supranormal or subnormal value of either CBF or CMRO2 must not 
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be interpreted alone but in terms of blood flow and metabolism coupling. Indeed, during 
anesthesia a proportional variation in CBF and CMRO2 is observed. On the contrary, 
normal blood flow-metabolism coupling may be impaired after traumatic brain injury 
(TBI). 
 
Compensatory mechanisms: 
When CBF decrease, CMRO2 first remains constant by increasing the oxygen extraction 
and increase in C(a-v)O2 results. 
However when this compensatory mechanism is exhausted, further decrease in CBF 
(<20 mL/100g/min) results in cellular suffering and neuronal dysfunction is observed with 
progressive synaptic transmission impairment initially and later loss of structural integrity 
of the cerebral cells: at a molecular level, oxygen deficit induces anaerobical glycolysis 
and lactic acid production. If this process persists, ATP depletion and subsequent ionic 
homeostasis failure following the Na/K pump dysfunction occurs. Moreover, enzymes 
activation following entry into the cells of calcium leads to cellular destruction, involving 
irreversible damages. 
The Table (1) presented below shows normal values of different parameter of CMRO2. 
 Approximate value 
  
Cerebral blood flow  50mL/100g/min 
Systemic arterial oxygen content (CaO2) 14-20mL/100mL 
Jugular venous oxygen content (CjvO2) 8-13mL/100mL 
Jugular venous oxygen saturation (SjvO2) 65% 
Cerebral arterio-venous oxygen content difference [C(a-v) O2 = Ca 
O2 – CjvO2] 
6.3mL/100mL 
Cerebral oxygen delivery (CDO2 = CBF × CaO2) 10mL/100g/min 
Cerebral metabolic rate of oxygen consumption [CMRO2 = CBF × 
C(a-v)O2] 
3.5mL/100g/min 
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 CBF is submitted to many modulations. Multiple physiological and pathological 
conditions are associated with CBF fluctuations. The major determinants of CBF will be 
presented now. 
 
Brain autoregulation: 
To maintain adequate metabolic conditions, CBF must be kept coupled to metabolism 
and independent of hemodynamic variations. Indeed, CBF is constant over a wide range 
of blood pressure. This phenomenon is called autoregulation - an ability of an organ to 
maintain its blood flow constant over a given pressure range- which represents an 
homeostatic and protective mechanism. Between a range of mean arterial pressure of 
50 to 150mmHg, CBF is constant despite variations in CPP. The cerebral arterioles 
constrict following an increase in CPP to avoid a raised ICP and inversely dilate in 
response to a fall in CPP. Outwards this interval, CBF is proportionally related to blood 
pressure. Myogenic, neurogenic and chemical-metabolic mechanisms are implicated in 
the brain’s autoregulation. However it seems to be primary a pressure-controlled 
mechanism. Indeed, thanks to their smooth muscle cells, cerebral vessels are able to 
adapt their diameters in response to variations in intraluminal pressure (Bayliss effect). 
Neurogenic and chemical-metabolic mechanisms act to a lesser degree on the cerebral 
vasculature. 
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Influence of PaCO2 on CBF: 
CBF depends also of variations in dioxide carbon partial pressure (PaCO2). A rise in 
PaCO2 increases CBF and inversely a decrease in PaCO2 is accompanied by a 
decrease CBF. The relation between PaCO2 and CBF is sigmoid, as shown below.  
Figure 4: Influence of PaCO2 on cortical blood flow in normotensive dogs. 
 
 
 
 
This figure shows that the maximal vasomodulation is seen with PaCO2 between 30 and 
70 mmHg. The vasomodulation is secondary to modification of the local acid-base 
balance. The link between PaCO2 and acid-base status is summarized by the equation 
below: 
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CO2+H2O → H2CO3 → HCO3- + H+ 
The increased dioxide carbon partial pressure acts indirectly via a rise in the free 
protons concentration around cerebral per arteriolar sheets which produces a rapid 
relaxation of the smooth muscle in the precapillary vessels. CO2 variation is a potent 
factor that influences CBF. Indeed, even minor changes in the PaCO2 produce variation 
in CBF: an increase in PaCO2 of 1 mmHg increases CBF by 2,5 to 4%. This regulation 
has therapeutical importance because controlled hyperventilation is used to modulate 
arterial partial pressure of CO2 delete and consequently diminishing the intracranial 
pressure. 
At this stage it is however important to remind that any reduction in brain pH induces 
vasodilatation and reciprocally any increase in brain pH induces vasoconstriction: thus 
lactic acid produced during anaerobic state is a powerful cerebral vasodilatator. 
 
Influence of PaO2 on CBF: 
Another factor modulating the CBF is PaO2. Indeed, CBF increases when PaO2 is 
comprised between 25 and 50mmHg. The relation between PaO2 and CBF is hyperbolic 
(see figure 4 and figure 5). The induced cerebral vasodilatation acts to prevent or correct 
cerebral tissue's ischemia. This mechanism seems to result from a direct action of 
oxygen on specific receptors and from an increase in acid lactic and adenosine (a 
vasodilatative metabolite) after sustained anaerobic conditions. Furthermore, the lack of 
oxygen is potentiated by a concomitant rise in PaCO2.  
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Neural influence on CBF: 
The neural control of the CBF, with both an extrinsic and intrinsic components, is of 
lesser importance compared to the factors previously described but completes the 
effects of metabolic-chemical substances and autoregulation. The extrinsic neurogenic 
control is mediated via the superior cervical sympathetic (innervation of carotid and 
vertebral arteries) and induces vasoconstriction to protect the brain against states of 
hyperperfusion. The parasympathetic fibers travel through the facial and superficial 
petrosal nerves. Their stimulation induces a vasodilatation of large and small vessels 
accompanied by an increased permeability of these latter. The intrinsic control is 
dependant of two different pathways: the locus ceruleus induces vasodilatation of the 
microcirculation following release of norepinephrine. The Raphe nuclei tend to have 
vasoconstrictive effects via serotonin secretion. 
The figure 5 below summarizes the effects on the CBF of the PaO2, PCO2 and 
autoregulation. 
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5. CLINICAL FEATURES OF RAISED INTRACRANIAL PRESSURE 
 
Unfortunately there are neither sensitive nor specific signs or symptoms which allow the 
physician to diagnosis promptly an increased ICP. 
Below are presented the etiologies of intracranial hypertension: 
• Cerebral tumors 
• Vascular etiologies : intracerebral hematoma, cerebral infarct, meningeal hemorrhage, 
cerebral thrombophlebitis 
• Traumatic etiologies :extradural, subdural,posttraumatic intracerebral hematoma, cerebral 
contusion 
• Hypertensive encephalitis 
• Infectious etiologies : cerebral abscess, encephalitis, bacterial meningitis 
• Congenital hydrocephaly 
• Medicinal etiologies (corticosteroids, vitamin A, tetracyclin..) 
• Toxic etiologies 
• Endocrinologic etiologies (Addison, hypoparathyroidism) 
• Chronic respiratory failure 
 
The list of clinical clues represents late features of this process and results from the 
herniation and compression of the brain tissue, a late and almost irreversible life 
threatening condition. Moreover there is no consistent correlation between the range of 
ICP and the severity of the symptoms, adding a difficulty in the management of the 
patient. 
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Symptoms: 
• Headaches (especially postural headaches awakening the patient at night) represent 
the most common encountered symptom. Its onset can be sudden as in intracranial 
hemorrhage, cerebral edema or progressive when the process results from a chronic 
evolution (intra-cranial tumor). Cough, position changes are often associated with a 
sudden rise in ICP and an exacerbation of headaches may be observed. Morning 
headaches result from an elevated ICP following supine position and to an increase 
in dioxide carbon partial pressure during the sleep, inducing a cerebral 
vasodilatation. 
• Nausea (which are often absent) and vomiting are a late feature in the course of an 
intracranial expanding process. The area postrema seems to play a role essentially 
for vomiting in toxic conditions. 
• Diverse changes of humor may be seen ranging from confusion, irritability and 
agressivity to coma according to the degree of ICP, to diffuse brain hypo perfusion 
and secondary brainstem compression. 
• Multiple visual alterations can be associated in patient developing increased ICP. 
The abducens nerve (VIth cranial nerve) has a long course up to the sinus 
cavernosus. Consequently it is highly sensitive to compressive process. An 
abducens nerve compression results in lateral rectus muscle paralysis and diplopia. 
The oculomotor nerve (IIId cranial nerve) can be affected when transtentorial 
herniation occurs: the temporal lobe and oculomotor nerve are compressed against 
the wall of the tentorium. Initially a reactive ipsilateral mydriasis is observed which 
becomes total and areactive later. Visual eclipses (intermittent fall in visual acuity) 
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are late onset and represent a severe intracranial hypertension with a major risk of 
optical atrophy. 
 
Clinical signs: 
• Because the subarachnoid space and the whole meninges surround the optical 
nerve, increased ICP will be transmitted to the second cranial nerve, impairing the 
axonal transport. This phenomenon results in the formation of a papilla edema, 
which can be unilateral, bilateral or absent even if the space-occupying lesion is 
consequent. Moreover papilloedema needs some delay to appear. Thus absence 
of this sign does not exclude raised ICP. 
•  Cushing’s reflex: as previously explained, the true driving pressure of CBF is 
considered to be CPP. The Cushing reflex represents a burst of systemic 
hypertension, in response to upper brain stem ischemia (the principal etiology is 
intracranial hypertension complicated by cerebral herniation, but primary vascular 
pathologies can be implicated). This response is induced by a central 
catecholaminergic discharge. If this response to brain stem’s ischemia is not 
deleterious, no treatment is needed. The associated bradycardia is presumed to 
be due to a stimulation of baro receptors located in the aortic arch and carotid 
sinuses as a regulatory response to raised systemic arterial pressure. 
• an alternance of hyperpnea (waxing/waning) and apnea can appear during an 
episode of raised ICP: The Cheyne-Stokes respiration indicates a diffuse injury 
without brain stem’s lesion. It is not associated with a deep coma. 
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• Neurogenic pulmonary edema presents as a severe complication following CNS 
injury, including direct or compressive brain stem lesion. The typical presentation 
is an acute respiratory distress (ARD) without an obvious pulmonary injury. This 
ARD results from a hydrostatic pulmonary edema due to cardiovascular over 
stimulation in order to maintain central perfusion. If no treatment is instored, then 
hydrostatic edema leads to a permeability or inflammatory edema due to 
capillaries lesions. The goal of treatment is to reduce brain stem's compression 
and pulmonary hypertension. 
 
Complementaries exams: 
In the course of an expanding intracranial process, abnormalities in the CT-scan can be 
detected. These suggestive findings include a shift of the cerebral midline (or even its 
rupture), obliteration of the basal cisterns (in healthy people, these cisterns appear as a 
black halo around the upper end of the brain stem), loss of sulci, ventricular collapse or 
enlargement according to the underlying pathology, edema, hematoma, hemorrhage or 
undetermined mass. 
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6. CEREBRAL MONITORING  
 
 
Clinical evaluation: 
 
Traumatic brain injuries can be classified as mild, moderate and severe: this distinction 
is based on the Glasgow coma scale (GCS) (Table 2), which represents a precious tool 
allowing clinicians to assess the level of consciousness of a patient. 
 
VARIABLES RESPONSE SCORE 
 
EYE 
       Open 
 
 
Spontaneously 
To verbal command 
To pain 
No response 
 
 
4 
3 
2 
1 
 
BEST MOTOR RESPONSE 
       To verbal command  
       To painful stimuli (pressure to 
nail beds) 
 
 
Obeys 
Localizes pain 
 
Flexion-withdrawal 
Flexion-abnormal 
(decorticate rigidity) 
Extension (decerebrate 
rigidity) 
No response 
 
 
6 
5 
 
4 
3 
 
2 
 
1 
 
BEST VERBAL RESPONSE 
(Arouse patient with painful 
stimulus if necessary) 
 
 
Oriented and converses 
 
Disoriented and converses
Inappropriate words 
Incomprehensible 
No response 
 
 
5 
 
4 
3 
2 
1 
 
Total  
 
3-15 
 
 
 
 
 
Mild injuries correspond to a 13-15 score, with a full neurological recovery. A moderate 
injury applies to patients with a 9-12 score, presenting with a stuporous or lethargic 
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state. A score between three and eight designs comatose patients who are prone to 
develop secondary brain injuries. For this reason, this population must be closely 
monitored in order to prevent such events. Recent pre-hospital and intra-hospital 
guidelines have been proposed to provide the best support to the patients. 
After moderate or severe traumatic head injuries, clinicians dispose of multiple tools in 
order to closely and continuously monitor the cerebral functions, including parameters 
such as cerebral blood flow, cerebral oxygen extraction, direct brain tissue’s 
oxygenation, intracranial pressure etc. As no unique tool allows monitoring adequately 
the global cerebral function, combination of monitoring are used in clinical practice. 
 
SjvO2 monitoring: 
Both continuous and intermittent measurements of jugular bulb venous oxygen 
saturation (SjvO2) are currently employed to detect episodes of global cerebral ischemia 
in particular following traumatic brain injuries 4. Detecting episodes of desaturation is 
primordial to allow clinicians to treat them rapidly, thus attempting to prevent 
neurological deficits. The SjvO2 represents a balance between cerebral metabolic needs 
and cerebral oxygen delivery: a saturation value of 65% is considered as physiologic.  
To monitor SjvO2 continuously, a 4 French fiber optic oxygen saturation catheter is 
inserted percutaneously into an internal jugular vein (the best side to monitor is still 
matter of debate). The tip of the catheter is introduced into the jugular bulb: its position is 
then confirmed by a lateral x-ray, showing the tip at the level of vertebral body C2. A 
heparinized saline solution is continuously infused to prevent blood clotting.  
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Each time SjvO2 falls below 50% for more than 15 minutes, a protocol is followed to 
identify the etiology of the desaturation. The figure (6) below shows the algorithm: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conform calibration of catheter by measuring 
SvO2 in blood sample drawn through the 
catheter 
R/o arterial hypoxia by measuring arterial SO2
R/O anemia by measuring blood hemoglobin concentration
Catheter SjvO2 < 50% 
R/O poor catheter position by 
examining light intensity 
If light intensity is poor, adjust 
head and/or catheter position 
Correct reduced CBF 
If blood SjvO2 > 50%, recalibrate 
catheter 
If SaO2 < 90%, correct hypoxia
If hemoglobin < 9mg/dl, 
correct anemia 
 
This tool is prone to some problems, limiting its clinical use: 
• compression of the tip of the catheter against the wall of the vessel occurs 
frequently 
• need for frequent recalibration 
• displacement of the catheter with head movement 
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• the samples can be contaminated by extra cerebral blood, falsing the true 
saturation of cerebral blood 
Furthermore SjvO2 reflects a global value of cerebral oxygenation, potentially missing 
episodes of focal ischemia: therefore a decreased SjvO2 results from increased cerebral 
oxygen extraction after ischemic phenomenon, but normal or increased values don’t 
exclude a local hypoxia. The measurement of SjvO2 is often associated with CBF 
measurement. 
The SjvO2 monitoring is invasive: for this reason, this technique should be limited to 
patients presenting high risks of hypoxic injuries. It is usually used in patients with 
severe head injury (SHI) (GCS less than 8 on admission or within 48 hours after the 
event) who carry the most important risk to present SjvO2 desaturation. For example, a 
study showed a total of 60 episodes of jugular venous oxygen desaturation in 45 
patients with SHI. Among them, 30 episodes in 20 patients were confirmed with a direct 
measurement of O2 saturation by a co-oximeter 5. 
Other authors believe that monitoring of SjvO2 is useless due to the technical difficulties 
emphasized above as well as because of the non-regional measure and because no 
study have demonstrated a beneficial effect of such monitoring. Complications are 
similar to central venous catheter. 
 
PtiO2 monitoring: 
A recent method to monitor brain tissue oxygenation and assessing directly the local 
brain PO2 (PtiO2) has been described 6. A flexible polarographic micro catheter is 
inserted into uninjured frontal white matter. The usefulness of such technology is, 
28 
however, not known due to limited information yet published in the literature. Indeed, 
wide range of PtiO2 (between 3 and 12mmHg) has been described in presence of a 
SjvO2 of 50% after severe head injuries precluding to determine the pathologic limits. 
Consequently, some studies have proposed 10 mmHg of PtiO2 as the minimal threshold 
before starting optimization treatment to restore CPP values above 60 mmHg. 
In comparison with SjvO2 measurement, this method does not require multiple 
calibrations. However, spontaneous drift may exist and must be looked for. The 
prevalence of infection or hemorrhage is very low, the risk / benefit ratio being in the 
favor of the latter. 
 
Intracranial pressure monitoring: 
Intracranial pressure monitoring is a standard technique in the management of patients 
presenting with severe head injuries (GCS ≤ 8).  
Even if no study has established its real benefit (there is no prospective randomized 
clinical trial and thus no data to support ICP monitoring as a standard application in the 
management of severe head injuries), it is now accepted as universal monitoring.  
Multiple studies tend to show that ICP monitoring: 
• Is useful in the early diagnosis of intracranial mass lesions. 
• Allows the physician not to provide excessive anti-hypertensive treatment. 
• Allows cerebrospinal fluid to be drained when an intraventricular device is used. 
• Helps in determining the prognosis. 
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Specific criteria have been proposed to help the physician to determinate the 
situations needing ICP monitoring: 
• The presence of an abnormal admission CT scan and severe head injuries 
(defined as a Glasgow score between 3 and 8),  
• After cardiopulmonary resuscitation for cardiac arrest. 
• Severe head injury with a normal CT scan if 2 or more of the followings are 
present: 40 years or older/a systolic blood pressure less than 90 mmHg/an 
unilateral or bilateral motor posturing. 
Many different devices are available: 
• Catheters 
• Hollow screws or bolt (Richmond® screw, Philly® bolt, Leeds® screw, Landy® 
screw) 
• Fiber optic transducer tip (Camino®) 
 
These multiple devices can be inserted into different locations: 
• The lateral ventricle: ventricular catheter and fiber optic transducer tip 
• Intraparenchymal: fiber optic transducer tip 
• Subdural and subarachnoid: Richmond®, catheter and fiber optic transducer tip 
• Epidural: Gaeltech®, Ladd®, Philips® 
The intraventricular system is considered as the Gold-standard technique and is based 
on the measurement of CSF pressure via a fluid filled catheter, communicating with a 
pressure transducer, allowing continuous ICP monitoring. A major limitation of its use is 
the absence of delineated lateral ventricles due to compression, precluding the insertion 
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of the catheter. Another limitation is the risk of infection. In comparison to non-ventricular 
methods the latter allows to drain CSF when required. Thus, due to the compliance 
curve of the intracranial system even a small decrease in intracranial volume may result 
in an important decrease of the ICP.  
The principal indication for the insertion of this device is the coupling of ICP monitoring 
and CSF drainage in selected patients. The main complications are infection (5-6%, with 
increasing risk with time), hemorrhage (intraventricular hemorrhage or hematoma occur 
in less than 2% and is often asymptomatic), incorrect position and apparition of 
neurologic deficits.  
The intraparenchymal device is the second currently used technique: this method brings 
similar results in comparison with intraventricular method. However measurement drift 
can occur and fluid drainage can not be performed. This method has gained popularity 
because of his insertion’s easiness and his ability to monitor the ICP independently of 
the head’s position. Recently, a prospective study showed that this system offered 
reliable ICP measurements in an acceptable percentage of device complications and the 
advantage of in vivo recalibration. The incidence of technical complications was low and 
similar to others devices 7. 
Figure 7: Intracranial pressure monitors 
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 Transcranial Doppler monitoring: 
This non-invasive technique is used to monitor the CBF velocity in cerebral arteries. 
Sound waves are sent through the skull, after they have reached moving substances, 
they are reflected back at different frequencies according to their velocity. The following 
vessels are monitored: the temporal window includes the ipsilateral middle, anterior, 
posterior cerebral arteries and the terminal internal carotid artery. Information on 
ophthalmic artery and carotid siphon are obtained through a transorbital window. The 
vertebral and basilar arteries are examined via a sub-occipital window. 
The results are obtained under the form of the systolic velocity (Vs), diastolic velocity 
(Vd), mean velocity (Vmean) and pulsatility index (Vs-Vd/Vmean), which represents the 
degree of variability in the maximal velocity occurring during a cardiac cycle. As control 
the middle cerebral artery is used: a normal velocity is comprised between 50 and 
80cm/s, with extremes tolerated until 120cm/s. Velocities above this value indicate a 
narrowing of the vessel or a major increase in CBF. 
 
Near-infrared spectroscopy (NIRS) monitoring: 
NIRS is a non-invasive method used to monitor the cerebral tissue oxygenation 8: this 
technique is based on the different light adsorption in the chromophore levels of 
oxyhemoglobin and deoxyhemoglobin. NIRS showed a great sensitivity and specificity in 
comparison with the SjvO2 in detecting cerebral ischemic conditions. In a study 
performed by Kirkpatrick and Coworkers, NIRS monitored twice as many desaturation 
events as with the jugular venous saturation monitoring system 9. Even if the reliability of 
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the NIRS method is not perfect (sensibility in the room temperature, sensitivity to the 
outside light), it seems to be a useful tool in the diagnosis of cerebral anoxia, in 
conjunction with the jugular venous saturation measurement. 
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 7. TRAUMATIC BRAIN INJURY 
We dispose of limited information concerning the sequence of events occurring after 
TBI.  A review of the physio-pathological events described in the current literature is 
presented below. 
  
Physio-pathological events following traumatic brain injury: 
TBI can result from multiple etiologies. Some of these injuries occur at the moment of 
the initial insult (primary injury) and thus cannot be prevented: they can be classified as 
laceration of cerebral tissue secondary to skull fractures, focal cerebral lesions 
(contusions, epi / subdural / intraparenchymal hematoma) and diffuse cerebral lesions 
(diffuse axonal injury). The distinction between focal and diffuse injury is critical because 
surgical intervention can be accomplished in the focal lesions only. 
Secondary brain injury includes the events occurring after the initial insult that 
exacerbate the primary brain injury and worsen the outcome. This concept is important 
as after a trauma, the brain becomes much more sensitive to aggressive conditions 
compared to uninjured brain. The worst secondary insults are systemic hypotension 
(defined as a systolic pressure below 90mmHg), hypoxemia (defined as a PaO2 below 
60mmHg 10-13, hyper / hypothermia, hyper / hyponatremia, hyper / hypoglycemia, 
infections, and / or seizures. Furthermore, initial insults may also per se induce 
secondary injuries through formation of compressive processes (brain edema, 
hematoma). Much attention is focused again the latter complications because they can 
be prevented or treated if detected early. For this reason, patients with multiple injuries 
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present a higher risk for a poor outcome when compared with patients presenting a 
mono-trauma. Hypotension being a major determinant of outcome from severe head 
injury (150% increase in mortality) 12, resuscitation protocols for brain injured patients 
should assiduously avoid hypovolemic shock on an absolute basis. 
The pathway between insult and cellular destruction is multi-factorial. Release from the 
injured cells of glutamate, an excitatory amino acid is one of them. The action of this 
neurotransmitter is located on the postsynaptic receptors (NMDA), whose stimulation 
allows passage of calcium and sodium ions in the cells. Subsequent activation of 
proteases, phospholipases, kinases and nitric oxid synthases induces free radical 
formation (O2-, H2O2, OH-, and NO) and cell’s integrity breakdown. Future research at 
blocking the release of this transmitter seems promising. 
In clinical practice, after traumatic brain injury, intracranial hypertension occurs mainly by 
formation of cerebral edema. Even if this latter is not necessarily deleterious, it may 
promote secondary injury by impairing regional (focal brain compression) or global CBF 
(ICP elevation). For this reason it represents a condition requiring immediate specific 
treatment. 
Brain edema is defined as an accumulation of fluid (water and sodium) in the cerebral 
parenchyma with a concomitant volumetric increase in brain’s tissue. Brain’s swelling 
results from multiple different pathological conditions, either from intracranial or from 
extra cranial etiologies (hepatic failure, ketoacidosis…). Cerebral vessels engorgement 
corresponds to the dilatation or venous outflow obstruction of cerebral vessels.  
The deleterious effects of brain edema, resulting in increase in ICP, are the direct 
consequence of global or focal impaired CBF secondary to vascular compression. A 
reduction of CBF below 20ml/100g/min is followed by cytotoxic edema, which is still a 
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reversible mechanism. CBF fall below 10 mL/100g/min induces irreversible damages. 
Ultimately, increasing edema may result in parenchymal herniation. 
 
Four types of edema have been reviewed in the literature 14 
• The cytotoxic edema occurs after sustained tissular hypoxia. Following ATP 
depletion, cell’s homeostasis is progressively lost: intracellular edema develops 
after accumulation of sodium in the cell.  
• The vasogenic edema is a consequence of increased vascular permeability, via 
opening of tight junctions or breakdown of the capillary endothelial cells (blood-
brain-barrier). Tumors, abscesses, contusion, hemorrhage, infarction, purulent 
meningitis are the main etiologies. A fluid rich in protein flows from the intra-
vascular to the extra-vascular compartment. This edema is localized principally in 
the white matter. Hypercapnia, hypoxia, increased CPP and hyperthermia 
exacerbate the edema. In contrast hyperventilation, hypotension and raised ICP 
decrease it. 
• Interstitial edema results from displacement of CSF into the periventricular 
tissues. The blood brain barrier is not broken: increase in CSF production or 
decrease in its resorption (obstructive hydrocephalus) leads to accumulation of 
fluid in the ventricular system. Due to the raised intraventricular hydrostatic 
pressure, a transsudate flows in the periventricular spaces. 
• Hydrostatic edema or Osmotic edema 
 
It has been demonstrated that three distinct hemodynamic phases occur after TBI 15 : 
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• During the first 24 hours following TBI, a state of hypo perfusion with decreased 
CBF prevails. The etiology is probably multifactorial and involves extrinsic micro 
vascular compression by damaged and edematous cells, mainly astrocytic 
process. In addition, muscular contraction resulting from a release of vasoactives 
metabolites is also observed. 
• The second phase begins at day one post-injury and ends at day three: a 
progressive increases in CBF is observed with peaking at 48-72 hours post injury. 
CBF does not increase to supranormal values but a relative hyperemia is 
frequently observed. Thus, CBF is often no more coupled to the brain’s 
metabolism (probably due to loss of vasomotor regulation), the latter being 
typically reduced. The resulting luxury perfusion may promote secondary brain 
injury. The range of this hyperemia and its relation to the increased ICP has 
actually not been well studied. Furthermore, its link with the outcome has not yet 
been established either. 
• The third phase is characterized by a severe vasospasm involving the proximal 
part of the middle cerebral arteries. It is first observed at day 4 post-injury and 
lasts for approximately three weeks. CBF can be dramatically reduced during this 
period with subsequent episodes of ischemia. The mechanism is poorly 
understood but presence of blood in the sub-arachnoid space seems necessary.  
To prevent recurrent aggression after brain trauma, guidelines have been developed 
to care of the patients from the scene of insult up to the hospital.  
General principles guiding the treatment of brain injured patients include airway 
management and hemodynamic support. Post-injury episodes of hypotension and/or 
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hypoxia were associated with a dramatic increase in mortality and morbidity. Below 
are presented the actual recommended guidelines from the brain trauma 
organization (www.braintrauma.org). 
 
 
Pre-hospital protocol: 
Endotracheal intubation has shown to be of great benefit in the management of isolated 
severe traumatic brain injuries, decreasing the mortality significantly. Short-lived 
neuromuscular blockade is usually associated to facilitate the intubation procedure. 
Hyperventilation is no more systematically recommended due to the demonstration of 
the occurrence of ischemia in injured brain tissue secondary to hypocapnia-induced 
cerebral arterioles vasoconstriction or through increasing the volume of hypoperfused 
tissue 16-18. As CBF already decreases in the 24 hours following a severe traumatic brain 
injury, the consequence of a further decrease may be deleterious for the suffering brain. 
Hypovolemic shock must be prevented if possible or diagnosed and treated when it 
occurs. Intra-vascular fluid resuscitation, usually with two liters of crystalloid is the first 
line of treatment. Hemodynamic end points targeted are a systolic blood pressure above 
90 mmHg and arterial blood saturation above 90%. It is interesting to note that these 
values are based more on a statistical validation rather than on individually adapted 
physio-pathological treatment. The choice of intravenous fluid to administrate is still 
matter of debate. No prospective randomized trial has been able to determine what 
solution was able to provide the best support in the prevention of systemic hypotension: 
isotonic crystalloid (with an initial bolus of two liters) is the recommended treatment. 
However, hypertonic saline solution has been proposed as an alternative 19,20. This 
38 
solution seems to decreases the ICP and concomitantly restores normal arterial blood 
pressure. A concern exists however that hypertonic saline solution may migrate into the 
brain through disturbed blood-brain-barrier and could enhance edema formation. 
 
 
 
8. INTRAHOSPITAL MANAGEMENT OF INTRACRANIAL 
HYPERTENSION 
 
Few prospective reports have been published on the interrelationships between ICP 
fluctuations and patients' outcome. However it is accepted that sustained intracranial 
hypertension represents a deleterious condition for the patient. The absolute value 
defining unacceptable ICP is still debated. In clinical practice it is however accepted that 
ICP> 20 mmHg requires treatment. Thus, intra-hospital guidelines have been developed 
to prevent and treat increased ICP in severe traumatic brain injuries 21. 
The listing of the recommended treatments modalities will now be provided.  
 
1. Non-specific treatment in presence of intracranial hypertension: 
• 30 degrees elevation of the head, in a neutral position (no hyperextension, flexion 
or lateral deviation) 
• Avoidance of jugular venous outflow obstruction 
• Control of the body temperature, i.e. maintain the patient to normothermic or even 
hypothermic values (however, no prospective randomized study has established 
the positive role of hypothermia) 
• Maintenance of an adequate arterial oxygenation and complete volume 
resuscitation to CPP around 60 mmHg 
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• Seizure prophylaxis 
• Sedation and eventual pharmacological paralysis 
 
 
2. Specific treatment in presence of intracranial hypertension: 
• If a ventricular catheter is in place CSF should be drained. However, small 
ventricles and swollen brain often prevent the use of catheter in acute phase 
following TBI.  
• A value of 35 mmHg of PaCO2 must be obtained with controlled mechanical 
ventilation if necessary. Note that prophylactic hyperventilation is no more 
recommended. If intracranial hypertension persists despite initiation of the 
therapies listed above, treatment modalities with a lower ratio of risk to benefit 
ratio should be envisaged. Controlled hyperventilation should be implemented to 
obtain PaCO2 in a range of 30-35 mmHg (if lower PaCO2 are targeted, 
measurement of SjvO2 must be used). 
• Even if mannitol has never been subjected to a controlled clinical trial, the use of 
an osmotic diuretic (primary mannitol) has revealed to be very effective in 
reducing ICP (15 minutes bolus infusions of mannitol every four hours with an 
initial dose of 0,5 to 1.0 g/kg). Continuous infusion at an equivalent dose rate has 
proven to be less effective. Monitoring of the patient’s volume status, electrolytic 
balance and serum osmolarity is warrant. The maximal response of ICP to 
osmotic diuretics occurs at osmolarity values between 295 and 310 mOsm: if 
osmolarity rises, then doses must be decreased. Loop diuretics (furosemide, 
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bumetanide) in conjunction with prior mannitol infusion are effective in reducing 
ICP. The presumed mechanisms of action of mannitol are as follows: 
- Immediate plasma expanding effect reducing hematocrit and thus blood 
viscosity, increasing CBF and cerebral oxygen delivery. 
- Osmotic effect occurring after 15-30 minutes persisting from 90 minutes to six 
hours. Mannitol is excreted exclusively in the urine. Excessive serum 
osmolarity (>320 mOsm) is associated with significant risk of acute renal 
failure. Mannitol is known to cause opening of the blood-brain-barrier. After 
repeated doses, mannitol is prone to accumulate in the brain causing reverse 
osmotic shift and increasing brain osmolarity, consequently possibly 
exacerbating ICP. 
• There are no results from randomized trials to confirm or refute the effectiveness of 
decompressive craniectomy in adults 22 . Barbiturate coma (effective in improving 
outcome but presenting significant complications), reserved to refractory intracranial 
hypertension, is described in different studies 23,24. High dose barbiturates therapy 
reduces the cerebral metabolic rate, induces cerebral vasoconstriction, hypothermia, 
cardiac inotropy and peripheral vasodilatation. 
• Glucocorticoids therapies are no more considered to be effective in treating severe 
head trauma. 
 
Specific supporting treatments of intracranial hypertension: 
In presence of persisting intracranial hypertension two different supporting treatments 
have been proposed.  
 The cerebral perfusion pressure targeted protocol 25,26
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 The intracranial pressure targeted protocol 27,28
 
1. The cerebral perfusion concept: 
In absence of specific therapy to restore the CBF regulation mechanisms, cerebral 
perfusion concept is used. In this protocol, a fixed value of CPP is targeted and obtained 
either with an increased arterial pressure alone or in association with an increase in 
cardiac output. These therapeutical goals are aim to avoid secondary ischemic episode 
providing theoretically sufficient tissue oxygenation even when ICP is above normal 
values. This is accomplished by maintaining normovolemia (hypervolemia is associated 
with complications such as pulmonary edema) and alpha-agonists (norepinephrine) 
infusions when CPP falls below 70 mm Hg, in order to raises MAP. Cardiac inotropes 
can be added. The optimal value of CPP is still matter of debate: McGraw et al 
observed, in a retrospective analysis, a correlation between CPP and outcome. Their 
result showed that the mortality rate was 35-40% when CPP was above 80mmHg. 
Furthermore, for each 10mm Hg decrease in CPP the mortality raised by 20% to reach 
95% when CPP was below 60mmHg 29. The morbidity and neurological deterioration 
paralleled the fall in CPP. Rosner described the outcome of 158 patients in whom CPP 
was kept above 70mm Hg at all times 25. Mean CPP was 83 +/- 14mm Hg. ICP 
averaged 27 +/- 12 mmHg. After 10,5 months post injury, mortality reached 29%, 
moderate disability 20% and good recovery 39%. In absence of control group, definitive 
conclusions are difficult to draw. Then preservation of CBF via a stable and high CPP 
seems to be associated with a significant decrease in mortality and improvement in 
quality of survival, even if recent studies tend to show that a higher CPP does not help in 
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achieving favorable outcomes 30-32. Actual recommendations tend to propose a value of 
CPP around 60 mmHg as therapeutical goal. 
 
2. The intracranial pressure concept: 
According to the Lund concept, disruption of the blood-brain-barrier occurs after TBI, 
secondary followed by brain edema. Thus, hypertensive therapy, via the resulting 
increased hydrostatic capillary pressure, tends to exacerbate the interstitial edema and 
thus to perpetuate the inflammatory stimulus, especially if autoregulation is impaired. 
Consequently, impairment of CPP due to raised ICP develops. Furthermore 
vasopressive substances could impair regional blood circulation in the contusions areas 
exacerbating cerebral microcirculation dysfunction.  
For Lund et al., intracranial hypertension (>20 mm Hg) represents the most powerful 
predictor of neurological worsening (defined as spontaneous decrease in GCS motor of 
2 points or more, loss of pupillary reactivity, development of pupillary asymmetry (more 
than 1 mm), deterioration in neurological status sufficient to necessitate medical or 
surgical intervention). Along this concept, CPP is considered to be of poor correlation 
with outcome as far as it is maintained above 60 mm Hg 33. Furthermore, sustained 
iatrogenic high CPP is associated with systemic complications such as ALI and ARDS 
34. ICP-targeted therapy aims at preventing the apparition of an uncontrolled intracranial 
hypertension following head injury. Simultaneously, drugs to maintain and/or improve 
the cerebral microcirculation (especially in the penumbra zone) are administrated, in 
order to reduce secondary insults. 
The specific steps of the Lund protocol are the followings: 
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• Surgical evacuation/CSF drainage to reduce the intracranial volume and improve 
the microcirculation  
• Reduction of intracapillary pressure through decreased arterial pressure with 
antihypertensive therapy (Metoprolol/Clonidine). 
• Constriction of precapillary vessels with low doses of thiopental and 
dihydroergotamine (limited to 5 days), and preservation of normal colloid force into 
the capillary.  
• Anti-stress therapy to minimize the level of cathecholamines in the plasma via the 
continuous infusion of low doses thiopental and fentanyl. 
• Low-dose prostacyclin to diminish the release of inflammatory substances. 
• Maintaining arterial normotension 
 
 
Few reports comparing the two protocols have been published. Recently, a randomized 
clinical trial 35 was performed in attempt to compare the effects of the two models on 
occurrence of refractory intracranial hypertension, frequency of jugular venous 
desaturation and long-term neurologic outcome in patients presenting with severe head 
injuries. 189 patients were included in this study and were assigned to either CBF-
targeted or ICP-targeted protocol during assigned time blocks. 
The CPP targeted protocol showed a reduction from 51% to 30% in the frequency of 
jugular desaturation episodes. The ICP strategy revealed a 2.4 greater risk of 
developing cerebral ischemia. However, there seems to have no difference in long-term 
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neurologic outcome between the two protocols. They concluded that secondary 
ischemic insults caused by systemic factors after severe head injury can be prevented 
with a targeted management protocol. However potential adverse effects of this strategy 
could offset the beneficial effects. 
The physio-pathological mechanisms occurring during and after TBI are extremely 
heterogeneous and not well-known. This represents an obstacle in the setting of an 
adequate treatment model. Consequently no universal guidelines have been 
established. Furthermore actual protocols to control intracranial hypertension are only 
supportive. Even if a renewed emphasis has been placed on managing severe head 
injury by elevating CPP, intracranial hypertension is still associated with considerable 
morbidity and mortality according to some authors. Thus there is controversy regarding 
ICP as opposed to CPP management.  
The two specific established protocols for the management of severe TBI lack of 
feedback on their respective influence on survival and long-term outcome. Limited 
information has been provided by the literature on the interrelationship between ICP 
fluctuations, CPP and outcome. 
 
9. AIM OF THE STUDY 
 
The aim of the present study was to systematically review the literature and summarize 
the available data to estimate the independent association between ICP and 
neurological and vital outcomes, to identify critical thresholds for ICP, and to explore if 
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sustained versus peak ICPs have a different prognostic significance, in patients with 
TBI. 
 
10. METHODS 
 
The search strategy was realized using MEDLINE (PubMed®, NLM), and the central 
COCHRANE Controlled Trial register to identify articles published between 1966 and 
December 2005. All searches were without language restriction and the following terms 
were used: “intracranial pressure", "severe head injury", "cerebral perfusion pressure ", 
"traumatic brain injury ", "intracranial hypertension", "outcome", "head trauma", 
"intensive care". These words were linked using the following combinations: "intracranial 
pressure AND outcome", " severe head injury AND outcome", "intracranial pressure 
AND cerebral perfusion pressure", "cerebral perfusion pressure AND outcome". 
Reference lists from the retrieved reports, recent review articles and systematic reviews 
were also checked to ensure completeness. No work published in abstract form only 
was included, if it did not provide relevant data. Authors were not contacted for original 
data. 
 
 
Inclusion Criteria, End Points and Definitions: 
 
The articles included had to be full reports on patients (adults and pediatrics groups) 
admitted to the hospital with a diagnosis of severe TBI, as established by the Glasgow 
Coma Scale (GCS) <8, and documented ICP monitoring during the intensive care unit 
(ICU) stay. The articles had to describe at least the initial treatment, the modalities of 
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ICP monitoring (type of device, duration of monitoring), and ICP treatment. Moreover 
they had to report ICP course over time and the outcome at 3, 6 or 12 months, as 
established by the Glasgow Outcome Scale (GOS) so that the association between ICP 
and outcome could be evaluated. The classification of level of evidence used for the 
development of "the Guidelines for the management of severe traumatic brain injury" 
was used to categorize the level of the publications 21. 
Class I studies included prospective randomized controlled trials. Class II designated 
comparative studies with prospectively collected data and retrospective analyses based 
on reliable data. This category included observational studies, cohort studies, 
prevalence studies, and case control studies. Class III studies contained retrospectively 
collected data (clinical series, databases, registries, case reviews, case reports, expert 
opinions). For completeness, class II and class III studies have been reported in the list 
of studies that were identified from our search. 
 
 
Data Extraction: 
 
One author (N.S.) screened the titles and abstracts of all reports retrieved, and all 
reports that did not explicitly meet our predefined inclusion criteria were excluded at this 
stage. Data abstraction of all remaining reports was done by three investigators (N.S., 
M.T. and J.A.R.) in tri plicate. 
Patients’ characteristics: We identified age, initial neurologic score (GCS), clinical 
characteristics, and presence of mass lesion involving surgery. 
Monitoring: We identified the type of ICP monitoring (intra-ventricular, epidural, sub-
arachnoid, intra-parenchymatous screw), the duration of ICP monitoring, the occurrence 
of complications related to the monitoring.  
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Specific treatments for raised ICP: the use and degree of hyperventilation, steroids, 
osmotic agents, CSF drainage, barbiturates, pharmacological paralysis and 
vasopressors, other ICP treatments were identified. 
Follow-up outcome measures: clinical neurological status at follow-up preferably 
assessed with the GOS at 3, 6 or 12 months.  
Intracranial pressure course: we noted the patterns of ICP course, and stratification of 
ICP values. We identified ICP response to targeted treatments. When available, we 
obtained information with regard to CPP, and we recorded the occurrence of 
hypotension (defined as a systolic blood pressure of < 90 mm Hg) and/or hypoxemia 
(defined as an arterial oxygen partial pressure < 60 mm Hg) prior to admission or during 
the hospital stay. 
 
Data Analysis: 
The eligible studies were compared for homogeneity. The primary aim of the present 
study was to estimate the association between ICP values and the GOS at one year 
following hospital discharge, using a proportional odds model. The score test for trend 
was used to assess the linear trend between worsening neurological outcome and 
increasing ICP values. In secondary analyses, we explored the association between ICP 
patterns and the GOS at one year following hospital discharge. Additionally, logistic 
models were fitted to compare the effect of increasing ICP on neurological outcomes. 
Odds ratios were computed for each level of neurological outcome relative to good 
outcome (good neurological status and moderate disability combined), as well as all 
poor neurological outcomes combined versus good outcome. We also estimated the 
strength of the association between ICP levels and mortality versus all other outcomes 
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at one year after hospital discharge. All analyses were performed using the statistical 
software STATA version 8.2 (Stata Corp, College Station, TX).  
 
11. RESULTS 
 
Characteristics of Trials Identified: 
A total of 555 articles were located from all the sources, with 225 mentioning ICP. No 
reports were translated. After exclusion of 330 articles not mentioning ICP management 
or ICP evolution (stratification or pattern), 66 articles identifying ICP management were 
located. Among those, 15 studies describing ICP management were relevant (Figure 8). 
We did not find Class I study evaluating ICP monitoring. Seven studies were found to 
report the information of interest (ICP patterns and/or values and their association with 
GOS). All reports were class II, with analysis of prospectively collected data.  
We identified several variables reported in the studies screened: age, presence of 
surgical mass, initial GCS, initial treatment, type and duration of ICP monitoring, use of 
head elevation, hyperventilation, steroids, osmotics agents, barbiturates, CSF drainage, 
volemic status and the occurrence of hypotension or hypoxemia prior to definitive 
medical management. The inclusion criteria for the studies describing ICP patterns 
were: inability to obey commands or utter recognizable words following injury and after 
appropriate cardiopulmonary resuscitation in the emergency room. Excluded patients 
were those with gunshots wounds to the head or those who already fulfilled the criteria 
of brain death. Five studies described ICP variations over time and categorized the 
values as “normal ICP” (< 20 mm Hg), elevated ( > 20 mm Hg) but reducible ICP”, and 
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“not reducible ICP” 36-40. One of them dichotomized the values as “normal ICP”, and 
“elevated ICP” with subsequent stratification in “high then normal”, “normal then high” 
and “elevated throughout”. One of these studies compared patients presenting 
intracranial mass lesions (ICML) and those presenting diffuse brain injury (DBI) 38. Four 
studies investigated the association of stratified ICP values with outcome, and provided 
sufficient data for a quantitative analysis 38,40-42. Two studies differentiated between 
patients with ICML or DBI 38,41. 
There was wide variability in the size of the trials (range 48-428 patients). Overall, the 15 
trials included 3032 patients (Table 3). 38% of the patients underwent intracranial 
surgery.  
We examined the different management protocols and ICP monitoring devices (Table 4 
and 5). An intra-ventricular catheter was employed for ICP monitoring in 77% (10 
studies) and CSF drainage was only used in 75% (9/12). The subarachnoid screw was 
the most frequently used technique (85%). The duration of ICP monitoring varied from 
48 hours to five days or longer. In 90% (9/10) of the evaluated studies the management 
protocol included steroid therapy during the first 24 hours and ICU stay. Only five of the 
recorded studies reported the use of an anti-seizure treatment. The majority of the 
studies (92%, 12/13) reported to apply hyperventilation (range 20-35 mm Hg). During 
the ICU stay, only Tsutsumi et al reported a fluid restriction protocol 42, whereas Ng et al 
tried to maintain normo-volemia with fluid boluses, and normal blood pressure with the 
infusion of vasopressors or inotropes 43. The other studies did not report the volemic 
targets and/or the amount or type of fluids administrated. Only Miller et al and Ng et al   
reported the use of head elevation as part of their protocol 38,43. Osmotic therapy, based 
on mannitol infusion was largely employed (13/15 studies). Barbiturates therapy was 
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considered among the possible treatment options, but the indications varied largely 
among the studies (Table 5).  
 
ICP values and neurological outcome: 
 A total of 409 patients were included from the four studies evaluating the association 
between ICP values and outcome (Table 6) 38,40-42. Patients with an ICP < 20 mm Hg, 
presented Good Recovery/Moderate Disability (GR/MD, respectively) in 69% of the 
cases, whereas the proportion was of 58 and 30% for ICP values comprised between 20 
and 40 and > 40 mm Hg, respectively. The proportional odds model indicated that the 
risk of worse neurological outcome (from poor neurological outcome to death) versus 
good outcome increased with progressively higher ICP levels: the odds ratio (OR) 
comparing ICP between 20 and 40 with ICP < 20 was 2.3 (95% CI: 1.37, 3.89), and the 
OR comparing ICP > 40 with ICP < 20 was 4.1 (95% CI: 2.65, 6.29). The test for trend of 
odds was significant (Score test for trend of odds, χ2 = 24.77, p < .01).  
The ORs of good versus all other outcomes were substantially decreased for patients 
experiencing ICP levels > 40, compared with patients maintaining normal ICP (OR: .19 
[95% CI: .11, .33]). However, the odds ratio of poor (Severely Disabled and Vegetative 
(SD/V, respectively)) versus good (GR and MD) neurological outcome was not 
significantly increased with raised ICP levels (1.6 [95% CI: .83, 3.10] for ICP 20-40 and 
1.6 [95% CI: .91, 2.81] for ICP > 40, with ICP < 20 as the reference category for all 
comparisons] (Table 7, Figure 9). The odds of death (D) relative to all other outcomes 
were severely increased with raised ICP: 2.9 [95% CI: 1.45, 5.60] for ICP 20-40 and 5.7 
[95% CI: 3.35, 9.59] for ICP > 40, with ICP < 20 as the reference category). 
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 ICP patterns and neurological outcome:  
ICP patterns were classified as normal, raised but reducible, and refractory ICPs; a 
normal ICP pattern was used as the reference. A total of 677 patients were included 
from the five studies evaluating the association between ICP patterns and outcome 36-40. 
Normal ICP was associated with good recovery (GR) or moderately disability (MD) in 
77% of the patients, in the four studies analyzed (Table 6). Compared with normal ICP, 
raising but reducible ICP was consistently associated with a decrease likelihood of 
GR/MD outcome (77% versus 50%, normal versus raised but reducible ICP, 
respectively), and with an increase in the proportion of patients described as severely 
disabled (SD), or vegetative (V) (7% versus 20%, normal versus raised but reducible 
ICP) , and dead (D) (17% versus 30, normal versus raised but reducible ICP). Refractory 
ICP, not responsive to specific treatments was associated with a dramatic increase in 
mortality (96%). The odds of good relative to all other outcomes were considerably 
reduced in patients with refractory ICP, compared with patients with normal ICP, and 
approached zero (OR: .01, 95%CI: .003, 0.32) (Table 8). The odds of good neurological 
outcome versus severe disability and vegetative state were nearly 5 times higher in 
patients with ICP patterns characterized by raised ICP that would lower in response to 
treatment, compared to normal ICP (OR: 4.7, 95% CI: 2.75, 8.17). Compared with 
normal ICP, a refractory ICP pattern was not associated with severe disability or 
vegetative state relative to good neurological outcome (OR: 3.8, 95% CI: .38, 38.3). This 
finding maybe explained by the fact that refractory ICP nearly entirely accounted for the 
mortality risk in this stratum of patients. The odds of death versus all other outcomes 
were dramatically increased in patients with refractory ICP, compared with patients with 
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normal ICP (OR: 114, 95% CI: 40.5, 322.3). The OR of death was increased in patients 
with ICP patterns characterized by raised ICP that would lower in response to treatment, 
compared to normal ICP (OR: 2.1, 95% CI: 1.41, 3.15). 
 
Additional informations from the original studies:  
One study reported the occurrence of hypotension in 16% of the patients, and 
hypoxemia in 37% during the ICU stay 39. Two studies stratified patients based on the 
type of brain injury, ICML and DBI, and estimated the association between recorded ICP 
values and outcome in each stratum 38,41. Neither of them observed a statistically 
significant difference between the two types of brain injury. 
Only one study recorded categories of CPP values, and their relationship with 
neurological outcome 42. The authors concluded that there was no significant outcome 
difference between patients with low mean CPP in the range 40 to 60 mm Hg and 
patients with CPP greater than 60 mm Hg. The mean CPP used in the analysis was 
obtained using the lower CPP value recorded in each patient. 
 
Conclusions in the Original Studies: 
Narayan et al concluded that ICP >20 mm Hg, requiring treatment and elevation of ICP 
at any stage was associated with a significant poorer prognosis as compared to patients 
demonstrating normal ICP. Similarly, Miller et al concluded that one of the important 
factors in predicting a poor outcome was an elevation of ICP > 20 mm Hg despite 
mechanical ventilation 39. Tsutsumi et al tried to obtain clinically relevant values of ICP 
and CPP as a guide to management and concluded that the critical level of CPP in the 
mortality of TBI was almost constant for a wide range of mean ICPs 42. The morbidity 
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became worse only when ICP exceeded 40 mm Hg. Marshall et al recommended ICP 
monitoring to control intracranial hypertension in patients with TBI, raised ICP being 
present in 55% of those patients 41. Kobayashi et al suggested that ICP monitoring could 
help physicians guiding therapy to prevent secondary insults in patients with diffuse 
cerebral edema 40. 
 
12. DISCUSSION 
 
 
The main finding of our systematic review is that despite the numerous trials performed 
on the outcome of patient with TBI and intracranial hypertension, no prospective 
comparative trial has been published so far investigating the effect of ICP values and 
monitoring on patient outcome. An explanation would be that ICP monitoring has been 
incorporated in clinical practice for the management of TBI in virtually all neurotrauma 
centers. Indeed, there has been recently growing evidence supporting the use of 
intracranial pressure monitoring 44-47. Therefore it would be difficult, if not impossible, to 
design a study with a non-monitored group of patients treated according to an empiric 
protocol independent of the ICP. Moreover in order to prove that ICP monitoring per se 
improves outcome, a prospective randomized study including approximately 768 
patients would be required. However, studies comparing the effect on outcome of 
different approaches to treat raised ICP would be extremely valuable. The present 
systematic review suggests that ICP levels and patterns were highly predictive of 
neurological outcome, although ICP patterns were much stronger indicators. Refractory 
ICP was strongly associated with a dramatic increase in the odds ratio of death, as 
compared with normal ICP. Similarly, an ICP pattern characterized by increased ICP 
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that responded to treatment was associated with poor neurological outcome and death, 
as compared with normal ICP pattern. ICP level was associated with proportionally 
worsening neurological outcome, with ICP greater than 40 being associated with at least 
a 4-fold increase in the odds of dying. In addition, it is worth mentioning that no 
information was available on neurological outcome beyond one year of follow up. 
This is the first study attempting to quantify the association between ICP values and 
GOS, or the effect of ICP response patterns on neurological outcome. Moreover in the 
few relevant trials screened, a marked heterogeneity in the treatment protocols made it 
difficult to compare and interpret the results. We found differences between the two 
studies performed by Miller et al 38-39: they did record neither the use of steroids nor the 
occurrence of hypotension and/or hypoxemia in their first series. Moreover adverse 
effects related to those events (hypotension and/or hypoxemia, inadequate 
hyperventilation) have been proved to have a deleterious effect on the outcome 12. The 
initial treatment and use of hyperventilation differed largely between studies. Differences 
in protocols published by Saul and Ducker between the first and the second treatment 
periods make it difficult to determine the independent effect of lowering the ICP 
treatment threshold on outcome 45. 
Based on the actual scientific literature, we cannot conclude that ICP is an independent 
factor in the prognosis of patients with TBI, and more importantly whether ICP 
monitoring improves patient outcome. There are insufficient data to support its use as a 
standard even if published clinical experiences indicate its potential benefits in the 
management of TBI patients. Since monitoring could be associated with complications 
such as infection or bleeding, a randomized study would be contributory to evaluate the 
role of ICP monitoring in the management of TBI patients. As it was previously indicated 
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for the use of the pulmonary artery catheter, erroneous interpretation of the data or 
inappropriate therapeutic decisions could affect patient outcome 48. Therapies used to 
control ICP such as severe prolonged hyperventilation can be deleterious and have 
been proven to worsen outcome in TBI patients 49,50. Cumulative doses of mannitol can 
exacerbate brain edema and thus ICP especially in areas of blood brain barrier 
disruption 51. Furthermore, the significance of raising ICP, its response to treatment, and 
their association with patient functional outcome need to be determined in well-
designed, prospective studies. 
One of the objectives of the present study was to explore if sustained (defined as an ICP 
greater than 20 mm Hg that persists for 5 minutes or longer) versus peak ICP (defined 
as sudden and short-lasting rise in ICP) showed a different prognosis. Even if it would 
be logical to consider the former as more deleterious for the brain than the latter, we 
could not identify data in the available literature supporting this view. 
Even if the importance of intracranial pressure elevations per se on outcome is 
recognized 37,38, current evidence emphasizes the role of cerebral perfusion pressure in 
the management of TBI patients 25, cerebral ischemia probably being the single most 
important secondary event affecting outcome after TBI. The maintenance of a CPP 
around 60 mm Hg could be related to reduced mortality and improvement in quality of 
life. However CPP treatment alone may not be enough to improve outcome 52. 
Therefore, the critical value of ICP and its interaction with CPP remains vastly unknown. 
Again a well-designed controlled prospective randomized study comparing CPP-
targeted protocol versus ICP-targeted protocol would be helpful. In conclusions, these 
summary data suggest that ICP pattern, and in particular refractory ICP and response to 
treatment of raised ICP could be better predictors of neurological outcome than absolute 
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ICP value. However, these finding require prospective validation from a large cohort 
study. Identifying measurable and clinically relevant outcomes or their surrogates is high 
priority in order to establish endpoints for the evaluation of treatments intended to lower 
ICP and improve outcomes in severe traumatic brain injury patients. The role of ICP 
monitoring is clearly important, but the effect of monitoring and of its duration could not 
be assessed from the available literature. 
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TABLE 3 
Demographic data of patients included in the screened studies 
 
Variable (n of studies) Mean ± SD* 
N of patients (n=15) 3032 
Mean age (n=11) 29.4 ± 6.1 
Admission GCS 
 n=5 
 n=5 
 n=3 
 
Mean admission GCS 
GCS 3-8 (%) 
GCS >8 (%) 
 
NA 
≤ 8 
≤ 7 
 
NA 
NA 
NA 
Mean ICP (n=4)  
0-20 mm Hg (%) 45.2 
21-40 mm Hg (%) 30.6 
>40 mm Hg (%) 24.2 
Number of episodes of raised ICP NA 
Duration if raised ICP NA 
Surgery (%) (n =11) 38 ± 6.4 
 
* Unless otherwise specified; NA, Not Available; ICP, Intracranial Pressure;  
GCS, Glasgow Coma Scale
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TABLE 4 
 Description of relevant studies, including study design, intracranial pressure (ICP) treatment protocol in the first 24 hours, and type 
of ICP monitoring 
 
Author & year 
ICP monitoring 
 
 
Comparative 
study 
Hyperventilation 
in the first 24h 
Steroids in 
the first 24h 
Anti-seizures 
the first 24h Intraventricular Subarachnoid Epidural 
Miller , et al, 1977  0 
 
1 
 
1 
 
1 
 
1 
 
1 
 
0 
Becker, et al, 1977 0 1 1 1 1 1 0 
Marshall, et al, 1979 0 1 1 NA 1 1 0 
Miller , et al, 1981 0 1 1 1 1 1 0 
Narayan, et al, 1981 0 1 1 1 1 1 0 
Narayan, et al, 1982 0 1 1 1 1 1 0 
Saul, et al, 1982 1 1 1 NA 1 1 0 
Kobayashi, et al, 1983 0 1 1 NA 0 1 1 
Tsutsumi, et al, 1986 0 1 1 NA 0 1 1 
Smith, et al, 1986 1 1 0 NA 0 1 0 
Alberico, et al, 1987 0 1 NA NA 1 1 0 
Marmarou, et al, 1991 0 NA NA NA NA NA NA 
Ng, et al, 1998 0 0 NA NA 1 0 1 
Juul, et al, 2000 0 NA NA NA NA NA NA 
Clifton, et al, 2002 1 1 NA NA 1* 0 0 
Summary estimates 3/15 12/13 9/10 5/5 10/13 11/13 3/13 
1: Yes; 0: No; NA: Not Available; ICP: intracranial pressure; * Intraventricular (46%) and intra-parenchymal (54%)
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TABLE 5 
    Description of relevant studies, describing the intracranial pressure (ICP) treatment protocol in the ICU 
 
Author & year 
 
 
Hyperventilation 
in ICU (values) 
 
Fluid restriction 
 
Head 
elevation 
 
Osmotics 
agents* 
 
Steroids 
 
Barbiturates 
 
CSF 
drainage 
Miller , et al, 1977    1  (25-35) 
 
NA 
 
1 
 
1 
 
1 
 
NA 
 
1 
Becker, et al, 1977  1  (20-35) NA NA 1 1 NA 1 
Marshall, et al, 1979  1  (25 ± 3) NA NA 1 1 1 NA 
Miller , et al, 1981  1  (20) NA NA 1 1 NA 1 
Narayan, et al, 1981  1  (NA) NA NA 1 1 NA 1 
Narayan, et al, 1982  1  (20) NA NA 1 1 NA 1 
Saul, et al, 1982  1  (NA) NA NA 1 1 1 1 
Kobayashi, et al, 1983  1  (25-30) NA NA 1 1 1 0 
Tsutsumi, et al, 1986  1  (NA) 1 NA 1 1 1 0 
Smith, et al, 1986  1  (25-30) NA NA 1 0 1 0 
Alberico, et al, 1987  1  (24) NA NA 1 NA 1 1 
Marmarou, et al, 1991  NA NA NA NA NA NA NA 
Ng, et al, 1998  0 0 1 1 NA 1 1 
Juul, et al, 2000  NA  NA  NA NA NA NA NA 
Clifton, et al, 2002  1  (>30) 0 NA 1 NA 1 1 
Summary estimates 12/13 1/3 2/2 13/13 9/10 8/8 9/12 
1: Yes; 0: No; NA: Not Available; CSF: Cerebrospinal Fluid, ICU: Intensive Care Unit; * Mannitol
 65 
TABLE 6 
Description of main clinical outcomes, stratified by intracranial pressure (ICP) patterns or values 
 
Outcome ICP Values 0 < ICP < 20             20 < ICP < 40            ICP > 40 
ICP Patterns 
Pattern 1                  Pattern 2          Pattern 3 
Total n of patients 
(n of studies) 
185 
(4) 
125 
(4) 
99 
(4) 
376 
(4) 
205 
(4) 
96 
(4) 
Glasgow Outcome Scale at hospital discharge 
GR/MD  NA NA NA NA NA NA 
SD/V  NA NA NA NA NA NA 
D  NA NA NA NA NA NA 
Mid-term  (3-12 months) Glasgow Outcome Scale 
GR/MD 128 (69.2%) 73 (58.4%) 30 (30.3%) 288 (76.6%) 102 (49.8%) 3 (3.1%) 
SD/V 23 (12.4%) 21 (16.8%) 14 (14.4%) 25 (6.7%) 42 (20.5%) 1 (1.0%) 
D 34 (18.4%) 31 (24.8%) 55 (55.6%) 63 (16.8%) 61 (29.8%) 92 (95.8%) 
Long-term (> 12 months) Glasgow Outcome Scale 
GR/MD NA NA NA NA NA NA 
SD/V NA NA NA NA NA NA 
D NA NA NA NA NA NA 
 
GR: good recovery; MD: moderate disability; SD: severe disability; V: vegetative; D: death; NA:  Not Available; Pattern 1: Normal 
ICP; Pattern 2: Raised but reducible ICP; Pattern 3: Refractory ICP
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Table 7 
Odds ratios and 95% confidence intervals [95% CI] of neurological outcomes at one year, across strata of ICP values 
 GOS 3-4 versus 
GOS 1-2 
GOS 5 (death) versus 
GOS 1-2 
GOS 5 (death) versus 
all other outcomes 
GOS 1-2 versus 
all others outcomes 
ICP < 20 -- -- -- -- 
ICP 20-40 1.6 [.83, 3.10] 3.5 [1.70, 7.29] * 2.9 [1.45, 5.60] * .62 [.39, 1.00] 
ICP > 40 1.6 [.91, 2.81]   6.9 [3.85, 12.37] * 5.7 [3.35, 9.59] * .19 [.11, .33] * 
GOS: Glasgow Outcome Score (1: good neurological outcome, 2: moderate disability, 3: severe disability, 4, vegetative, 5: death); 
ICP: intracranial pressure; ICP < 20: reference category for all comparisons; * p < .01. 
 
Table 8 
Odds ratios and 95% confidence intervals [95% CI] of neurological outcomes at one year, comparing ICP patterns 
 GOS 3-4 versus 
GOS 1-2 
GOS 5 (death) versus 
GOS 1-2 
GOS 5 (death) versus 
all other outcomes 
GOS 1-2 versus 
all others outcomes 
Normal ICP -- -- -- -- 
Raised but reducible ICP    4.7 [2.75, 8.17] * 2.7 [1.80, 4.15] * 2.1 [1.41, 3.15] * .30 [.21, .43] * 
Refractory ICP 3.8 [.38, 38.29]   140.2 [43.00, 457.03] *   114.3 [40.51, 322.33] *  .009 [.003, .032] * 
GOS: Glasgow Outcome Score (1: good neurological outcome, 2: moderate disability, 3: severe disability, 4, vegetative, 5: death); 
ICP: intracranial pressure; Normal ICP: reference category for all comparisons; * p < .01. 
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Figure 8 
 
 Flow chart of the literature search and study selection for association between intracranial pressure and outcome. n= 
number of studies 
555 reports screened 
66 reports involving ICP management 
15 reports including ICP description 
225 reports mentioning ICP 
Reports not evaluating the stratification of ICP related to the outcome (n=8) 
Reports not evaluating a precise description of ICP course (n=51) 
Reports not meeting the inclusion criteria (n=159) 
Not relevant reports (n=330) 
7 reports including ICP stratification or ICP pattern
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